Edelman R, Russell R G, Losonsky G, Tall B D, Tacket C O, Levine M M, Lewis D H
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
Vaccine. 1993;11(2):155-8. doi: 10.1016/0264-410x(93)90012-m.
We have searched for an effective oral delivery system for a purified enterotoxigenic Escherichia coli (ETEC) fimbrial adhesin, CFA/I, which elicits anti-colonization immunity. Purified CFA/I antigen encapsulated in biodegradable polymer microspheres of poly (DL-lactide-co-glycolide) (PLG) induced a vigorous, systemic CFA/I IgG antibody response in rabbits immunized once via intragastric tube; oral, unencapsulated CFA/I induced little or no circulating antibody. CFA/I-specific, S-IgA coproantibody was detected in one of three rabbits fed with the CFA/I-PLG microsphere vaccine. We conclude that PLG microspheres protected CFA/I from degradation in the stomach and effectively delivered the antigen for processing by the host's immune system.
我们一直在寻找一种有效的口服给药系统,用于一种纯化的产肠毒素大肠杆菌(ETEC)菌毛黏附素CFA/I,它能引发抗定植免疫。包裹在聚(DL-丙交酯-共-乙交酯)(PLG)可生物降解聚合物微球中的纯化CFA/I抗原,通过胃管对兔子进行一次免疫后,可诱导强烈的全身性CFA/I IgG抗体反应;口服未包裹的CFA/I几乎不诱导或不诱导循环抗体。在三只喂食CFA/I-PLG微球疫苗的兔子中,有一只检测到了CFA/I特异性的分泌型IgA共同抗体。我们得出结论,PLG微球可保护CFA/I在胃中不被降解,并有效地递送抗原以供宿主免疫系统处理。